{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:49:07Z","timestamp":1790372947978,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Methicillin-resistant Staphylococcus aureus (MRSA) polymerase-chain-reaction nasal swabs (PCRNS) are a rapid diagnostic tool with a high negative predictive value. A PCRNS plus education \u201cbundle\u201d was implemented to inform clinicians on the utility of PCRNS for anti-MRSA therapy de-escalation in respiratory tract infections (RTI). The study included patients started on vancomycin with a PCRNS order three months before and after bundle implementation. The primary objective was the difference in duration of anti-MRSA therapy (DOT) for RTI. Secondary objectives included hospital length of stay (LOS), anti-MRSA therapy reinitiation, 30-day readmission, in-hospital mortality, and cost. We analyzed 62 of 110 patients screened, 20 in the preintervention and 42 in the postintervention arms. Mean DOT decreased after bundle implementation by 30.3 h (p = 0.039); mean DOT for patients with a negative PCRNS decreased by 39.7 h (p = 0.014). Median cost was lower after intervention [USD$51.69 versus USD$75.30 (p &lt; 0.01)]. No significant difference in LOS, mortality, or readmission existed. The bundle implementation decreased vancomycin therapy and cost without negatively impacting patient outcomes.<\/jats:p>","DOI":"10.3390\/pharmacy8020101","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T05:02:24Z","timestamp":1591938144000},"page":"101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Nasal Swabs on Empiric Treatment of Respiratory Tract Infections (INSERT-RTI)"],"prefix":"10.3390","volume":"8","author":[{"given":"Vanessa","family":"Huffman","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Memorial Hospital West, Pembroke Pines, FL 33028, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-9148","authenticated-orcid":false,"given":"Diana Carolina","family":"Andrade","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Hospital West, Pembroke Pines, FL 33028, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Ham","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Hospital West, Pembroke Pines, FL 33028, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-0105","authenticated-orcid":false,"given":"Kyle","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Memorial Hospital West, Pembroke Pines, FL 33028, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Melnitsky","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Memorial Hospital West, Pembroke Pines, FL 33028, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lopez Cohen","sequence":"additional","affiliation":[{"name":"Department of Graduate Medical Education, Memorial Hospital West, Pembroke Pines, FL 33028, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences, Larkin College of Pharmacy, Miami, FL 33169, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"ref_1","unstructured":"(2020, March 24). Antibiotic Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1086\/533594","article-title":"Pneumonia caused by methicillin-resistant Staphylococcus aureus","volume":"46","author":"Rubinstein","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc4934","article-title":"Morbidity and cost burden of methicillin resistant Staphylococcus aureus in early onset ventilator associated pneumonia","volume":"10","author":"Shorr","year":"2006","journal-title":"Crit Care."},{"key":"ref_4","first-page":"261","article-title":"The Daniel K. Inouye College of Pharmacy Scripts: The effects of vancomycin use and de-escalation in patients hospitalized with pneumonia","volume":"77","author":"You","year":"2018","journal-title":"Hawaii J. Med. Public Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"182.e1","DOI":"10.1016\/j.amjmed.2009.05.031","article-title":"Vancomycin-associated nephrotoxicity: Grave concern or death by character assassination?","volume":"123","author":"Hazlewood","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9343(93)90356-T","article-title":"Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia","volume":"95","author":"Cantral","year":"1993","journal-title":"Am. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciy024","article-title":"The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: A diagnostic meta-analysis with antimicrobial stewardship implications","volume":"67","author":"Parente","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.diagmicrobio.2016.08.011","article-title":"Clinical utility of a nasal swab methicillin-resistant Staphylococcus aureus polymerase chain reaction test in intensive and intermediate care unit patients with pneumonia","volume":"86","author":"Giancola","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.01805-13","article-title":"Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia","volume":"58","author":"Dangerfield","year":"2014","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcrc.2016.11.008","article-title":"Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction assay in critically ill patients with nosocomial pneumonia","volume":"38","author":"Smith","year":"2017","journal-title":"J. Crit. Care"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mergenhagen, K.A., Starr, K.E., Wattengel, B.A., Lesse, A.J., Sumon, Z., and Sellick, J.A. (2019). Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship. Clin. Infect. Dis., ciz974.","DOI":"10.1093\/cid\/ciz974"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2146\/ajhp140820","article-title":"Using active methicillin-resistant Staphylococcus aureus surveillance nasal swabs to predict clinical respiratory culture results","volume":"72","author":"Hiett","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jinf.2018.08.004","article-title":"MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis","volume":"77","author":"Cheng","year":"2018","journal-title":"J. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1017\/ice.2017.308","article-title":"The role of negative methicillin-resistant Staphylococcus aureus nasal surveillance Swabs in predicting the need for empiric vancomycin therapy in intensive care unit patients","volume":"39","author":"Chotiprasitsakul","year":"2018","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1097\/CCM.0b013e3181eeda3f","article-title":"Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment","volume":"38","author":"Sarikonda","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.21037\/jtd.2016.07.28","article-title":"Antibiotic stewardship in the intensive care unit: Tools for de-escalation from the American Thoracic Society Meeting 2016","volume":"8","author":"Akrami","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ajic.2014.05.026","article-title":"Nasal screening is useful in excluding methicillin-resistant Staphylococcus aureus in ventilator-associated pneumonia","volume":"42","author":"Langsjoen","year":"2014","journal-title":"Am. J. Infect. Control"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Baby, N., Faust, A.C., Smith, T., Sheperd, L.A., Knoll, L., and Goodman, E.L. (2017). Nasal methicillin-Resistant Staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02432-16"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2146\/ajhp160964","article-title":"Impact of a pharmacist-driven methicillin-resistant Staphylococcus aureus surveillance protocol","volume":"74","author":"Willis","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11096-018-0647-3","article-title":"Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia","volume":"40","author":"Dunaway","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_24","first-page":"e6378","article-title":"Impact of a pharmacist-driven methicillin-resistant Staphylococcus aureus polymerase chain reaction nasal swab protocol on the de-escalation of empiric vancomycin in patients with pneumonia in a rural healthcare setting","volume":"11","author":"Dadzie","year":"2019","journal-title":"Cureus"},{"key":"ref_25","first-page":"743","article-title":"Drug-Induced Nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: Building an International Community of Software Platform Partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/JCM.02972-13","article-title":"Concordance of PCR and culture from nasal swabs for detection of methicillin-resistant Staphylococcus aureus in a setting of concurrent antistaphylococcal antibiotics","volume":"52","author":"Shenoy","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clinthera.2011.12.013","article-title":"Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: Retrospective analysis of the IMPACT-HAP database","volume":"34","author":"Cano","year":"2012","journal-title":"Clin. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: A retrospective multivariate regression analysis","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/2042018816638223","article-title":"Review of vancomycin-induced renal toxicity: An update","volume":"7","author":"Bamgbola","year":"2016","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.chest.2018.10.014","article-title":"Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia","volume":"155","author":"Cowley","year":"2019","journal-title":"Chest"}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/8\/2\/101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:37:50Z","timestamp":1760175470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/8\/2\/101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["pharmacy8020101"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy8020101","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]}}}